Amyloid‐related imaging abnormalities from trials of solanezumab for Alzheimer's diseaseChristopher Carlson, Jerome Barakos, Roza Hayduk et al.|Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring|2016Cited by 65
[P1–044]: SAFETY OF SOLANEZUMAB IN PHASE 3 STUDIES IN INDIVIDUALS WITH MILD ALZHEIMER's DISEASE DEMENTIAChristopher Carlson, Eric Siemers, Greg Anglin et al.|Alzheimer s & Dementia|2017Cited by 1